title: Prospects for eradication of therapy-induced myelosuppression.
authors.affiliation: M.D. Anderson Cancer Center, Houston, TX.
authors.forename: G
authors.initials: G
authors.lastname: Ventura
authors.forename: G
authors.initials: G
authors.lastname: Spitzer
authors.forename: J
authors.initials: J
authors.lastname: Hester
authors.forename: A
authors.initials: A
authors.lastname: Deisseroth
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001685:Biological Factors / Q000627:therapeutic use; D001804:Blood Transfusion, Autologous; D001853:Bone Marrow / Q000187:drug effects*; D002986:Clinical Trials as Topic; D016207:Cytokines; D006410:Hematopoiesis / Q000187:drug effects; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006801:Humans
chemical_list: D000970:Antineoplastic Agents; D001685:Biological Factors; D016207:Cytokines